WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
New Stock Preview | Yu Research Hall submitted to the Hong Kong Stock Exchange to construct a modern traditional Chinese medicine service system with a "full life cycle diagnosis and treatment model"
JD Health (06618) launches evidence-based medicine AI product "Zhiyi" to assist doctors in clinical and research scenarios.
New Stock Outlook | Sunmi Technology: The Internet of Things NETDRAGON is trapped in the dilemma of "increasing revenue without increasing profits", with the question of customer loss year after year questioning the growth.
New Stock Preview | Yu Research Hall submitted to the Hong Kong Stock Exchange to construct a modern traditional Chinese medicine service system with a "full life cycle diagnosis and treatment model"
JD Health (06618) launches evidence-based medicine AI product "Zhiyi" to assist doctors in clinical and research scenarios.
New Stock Outlook | Sunmi Technology: The Internet of Things NETDRAGON is trapped in the dilemma of "increasing revenue without increasing profits", with the question of customer loss year after year questioning the growth.
